Review Article
Adjuvant Treatment of Melanoma
Table 12
High risk melanomas: adjuvant treatment with low and intermediate dose interferon.
| Trial | No. of cases | SLE | OS |
| Low dose IFN (3 mU × 3/s × 3 y.): | | | | WHO-16 (Cascinelli et al.2001) [47] | 426 | NS | NS | UK [48] | 674 | NS | NS | Scottish study (2001) [49]** | 59 | NS | NS | Ultralow dose IFN (1 mU): | | | | EORTC/DKG-80 (Eggermont. 2001) [50] | 830 | NS | NS | Low dose INF + Isotretinoin (IFN: 3 mU × 3/s × 2 y.) | | | | ECAMTSG ([51]) | 407 | NS | NS | Intermediate dose IFN. | | | | EORTC 18952* | 1388 | NS | NS | (10 mill. 13 m versus 5 mill. 25 m. versus observation) |
|
|
Eggermont et al. Semin. Oncol. Spanish Ed. 3, 221–227, 2003*. Hancock et al. J. Clin. Oncol. 22, 53–61, 2004 [48]. Cameron et al. BJC. 84(9): 1146–1149, 2001** Richtig et al. JCO. 23, 34, 2005 [51].
|